Physician profile
Andrew Chu
NPI 1538572243
$4,201.13
in general payments reported to CMS, 2019-2025
30 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,069 · 2020: $550 · 2021: $966 · 2022: $479 · 2023: $583 · 2024: $340 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $827.55 | 2019-2021 | |
| Stryker Corporation | $591.38 | 2021-2022 | |
| Smith+Nephew, INC. | $499.69 | 2019-2025 | Renasys Touch, Renasys Go V2 Home |
| Integra Lifesciences Corporation | $362.12 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Zimmer Biomet Holdings, INC. | $283.22 | 2020-2021 | |
| Organogenesis INC. | $278.47 | 2021-2025 | Via Matrix |
| Wright Medical Technology, INC. | $174.29 | 2019-2020 | |
| Nevro Corp. | $122.91 | 2022-2023 | Senza |
| Paratek Pharmaceuticals, INC. | $114.96 | 2023-2025 | Nuzyra |
| Paragon 28, INC. | $101.09 | 2019 | |
| Polynovo North America LLC | $74.49 | 2023-2025 | Novosorb Btm |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.53 | 2019-2023 | Jublia |
| Acera Surgical, INC. | $62.40 | 2025 | Restrata Wound Matrix |
| Ibsa Pharma INC. | $58.07 | 2023-2024 | Tirosint, Licart, Tirosint |
| Melinta Therapeutics, LLC | $56.02 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $55.45 | 2023 | Miro3d |
| Averitas Pharma INC. | $53.70 | 2023-2024 | Qutenza |
| Inari Medical, INC. | $51.03 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Mimedx Group, INC. | $49.69 | 2024 | |
| Tactile Systems Technology INC | $48.03 | 2020-2023 | Entre Plus, Flexitouch Plus |
| Bioventus LLC | $47.64 | 2019-2021 | |
| Alfasigma USA, INC. | $39.98 | 2021 | |
| Horizon Therapeutics Plc | $33.61 | 2019 | |
| Viiv Healthcare Company | $31.90 | 2019 | |
| Depuy Synthes Sales INC. | $27.63 | 2023-2024 | Va-Lcp |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.39 | 2023 | Xifaxan |
| Next Science LLC | $20.94 | 2021 | |
| Zyla Life Sciences, INC. | $18.94 | 2020 | |
| Tei Medical INC. | $14.85 | 2019 | |
| Saxum Surgical, INC. | $14.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.